Insulin resistance (IR), physiologically defined as a state of reduced responsiveness of insulin-targeted tissues to high physiologic insulin levels, is recognised as a causative driver of many modern diseases, including metabolic syndrome, nonalcoholic fatty liver disease, atherosclerosis, and type II diabetes [10]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.